Phase 1/2 Study of HS-10375 in Patients with Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC)

Clinical trial NCT05435248 · RECRUITING

Trial details

NCT number: NCT05435248
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced or Metastatic NSCLC

Start date: 2022-03-02
Primary completion: 2025-03-31
Enrollment: 354

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.